• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • 首都科技期刊卓越行动计划
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
张子怡,赵艳洁,刘璐,等. 乳脂肪球膜磷脂的添加对婴儿配方奶粉乳液体外消化特性的影响J. 食品工业科技,2026,47(15):1−11. doi: 10.13386/j.issn1002-0306.2025080104.
引用本文: 张子怡,赵艳洁,刘璐,等. 乳脂肪球膜磷脂的添加对婴儿配方奶粉乳液体外消化特性的影响J. 食品工业科技,2026,47(15):1−11. doi: 10.13386/j.issn1002-0306.2025080104.
ZHANG Ziyi, ZHAO Yanjie, LIU Lu, et al. Impact of Milk Fat Globule Membrane Phospholipids Addition on the In Vitro Digestion Characteristics of Infant Formula EmulsionsJ. Science and Technology of Food Industry, 2026, 47(15): 1−11. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025080104.
Citation: ZHANG Ziyi, ZHAO Yanjie, LIU Lu, et al. Impact of Milk Fat Globule Membrane Phospholipids Addition on the In Vitro Digestion Characteristics of Infant Formula EmulsionsJ. Science and Technology of Food Industry, 2026, 47(15): 1−11. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2025080104.

乳脂肪球膜磷脂的添加对婴儿配方奶粉乳液体外消化特性的影响

Impact of Milk Fat Globule Membrane Phospholipids Addition on the In Vitro Digestion Characteristics of Infant Formula Emulsions

  • 摘要: 乳脂肪球膜(Milk Fat Globule Membrane,MFGM)是乳中重要活性成分,因其健康效应已被应用到婴儿配方奶粉(以下简称婴配粉)中。前期研究发现,当MFGM磷脂与乳清蛋白以最佳比例(MFGM磷脂:乳清蛋白=5:10)添加时,婴配粉乳液的物理和乳化稳定性更佳,但其消化特性尚未展开研究。因此,本研究以母乳(Human Milk,HM)、市售含MFGM婴配粉(IF1,MFGM磷脂:乳清蛋白≠5:10)和不含MFGM婴配粉(IF2)作为对照,旨在探讨MFGM磷脂与乳清蛋白最佳添加比例(MFGM磷脂:乳清蛋白=5:10)对婴配粉乳液体外消化特性的影响。结果表明,以此比例添加的婴儿配方奶粉乳液(Infant Formula Emulsion,FE)在体外消化过程中表现出与HM相似的粒径变化(平均粒径3.28±0.24 μm,HM平均粒径4.24±0.31 μm)、电位变化(整体的电位值呈下降趋势)和微观结构变化(均有完整的脂肪球和磷脂环结构),且游离脂肪酸组成与含量的分布趋势与HM最为接近,其脂解程度(81.46%±0.75%)也更接近HM(85.49%±1.89%),优于市售IF1(75.35%±1.17%)和IF2(73.47%±1.28%)。综上,以此条件制备的婴儿配方奶粉乳液展现出与母乳更为相似的体外消化特性,本研究可为婴儿配方奶粉中MFGM的母乳化构建提供理论依据。

     

    Abstract: Milk fat globule membrane (MFGM) is a key bioactive component in milk, incorporated into infant formula due to its health benefits. Previous studies have found that adding MFGM phospholipids to whey protein at an optimal ratio (MFGM phospholipids:whey protein=5:10) enhances the physical and emulsifying stability of infant formula emulsions. However, its digestive characteristics remain unexplored. Consequently, this study employed human milk (HM), a commercial MFGM-containing infant formula (IF1, MFGM phospholipid:whey protein ≠5:10), and a commercial MFGM-free infant formula (IF2) as controls. The objective was to investigate the effect of the optimal MFGM phospholipids-to-whey protein ratio (MFGM phospholipid:whey protein=5:10) on the in vitro digestive characteristics of infant formula emulsions. Results indicated that infant formula emulsion (FE) supplemented with this ratio exhibited particle size changes (mean particle size 3.28±0.24 μm; HM mean particle size 4.24±0.31 μm), potential changes (overall decreasing potential trend), and microstructural alterations (both exhibiting intact fat globules and phospholipid ring structures). Furthermore, the distribution trends of free fatty acid composition and content were closest to HM, and its degree of lipolysis (81.46%±0.75%) was also closer to HM (85.49%±1.89%), surpassing commercial IF1 (75.35%±1.17%) and IF2 (73.47%±1.28%). In summary, the FE prepared under these conditions exhibits in vitro digestive characteristics more similar to HM. This study can provide a theoretical basis for the humanization of MFGM in infant formula.

     

/

返回文章
返回